2137 Comparison of two Phase II trials of mFOLFOX6 plus bevacizumab (KSCC0802) and SOX (S-1 and oxaliplatin) plus cetuximab (KSCC1002): First line chemotherapy in colorectal cancer patients with initially unresectable or not optimally resectable liver only metastases. (September 2015)

• Record Type: Journal Article
• Authors: Oki, E.; Emi, Y.; Miyamoto, Y.; Ogata, Y.; Tokunaga, S.; Shirabe, K.; Beppu, T.; Uchida, S.; Takatsuki, M.; Sakoda, M.; Eguchi, S.; Akagi, Y.; Kakeji, Y.; Baba, H.; Natsugoe, S.; Maehara, Y.
• Is Part Of: European journal of cancer. Volume 51:(2015)Supplement 3
• Page Start: S378
• Publication Date: 2015-09
• Subjects: Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Cancer; Tumors; Electronic journals; Periodicals; Electronic journals; 616.994
• DOI: 10.1016/S0959-8049(16)31058-9
• Languages: English
• ISSNs: 0959-8049